NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Alliance (UK). Cystic Fibrosis: Diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2017 Oct 25. (NICE Guideline, No. 78.)
Table 34Acquisition cost of appetite stimulants
| Stimulant | Dose | Unit cost | Cost/day | Cost/month |
|---|---|---|---|---|
| Cyproheptadine hydrochloride, periactin 4mg tablets (30, £5.99)a | 4mg qds (Homnick 2004) | £0.20 | £0.80 | £24.28 |
| Megace 160mg tablets (30, £19.52)b | 10 mg/kg/day (Eubanks 2002 & Marchand 2000) | £0.65 | £1.95c | £59.34c |
| Megestrol 200mg/5ml oral suspension (NR, NR) | NR | NC | NC | NC |
NC, not calculable; NR, not reported
- (a)
Taken from the BNF November 2016
- (b)
Taken from the NHS Electronic Drug Tariff November 2016
- (c)
Approximate for a weight of 50kg requiring 3 tablets to provide 480mg
- Table 34, Acquisition cost of appetite stimulants - Cystic FibrosisTable 34, Acquisition cost of appetite stimulants - Cystic Fibrosis
Your browsing activity is empty.
Activity recording is turned off.
See more...